IMCR
Price:
$33.4
Market Cap:
$1.67B
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma,...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
IMCR
According to Immunocore Holdings plc’s latest financial reports and current stock price. The company's current Enterprise Value is 1.64B. This represents a change of -31.45% compared to the average of 2.39B of the last 4 quarters.
The mean historical Enterprise Value of Immunocore Holdings plc over the last ten years is 1.40B. The current 1.64B Enterprise Value has changed 11.59% with respect to the historical average. Over the past ten years (40 quarters), IMCR's Enterprise Value was at its highest in in the December 2023 quarter at 2.98B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.
Average
1.40B
Median
919.96M
Minimum
819.20M
Maximum
2.98B
Discovering the peaks and valleys of Immunocore Holdings plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 110.20%
Maximum Annual Enterprise Value = 2.98B
Minimum Annual Increase = -4.08%
Minimum Annual Enterprise Value = 819.20M
Year | Enterprise Value | Change |
---|---|---|
2023 | 2.98B | 57.45% |
2022 | 1.89B | 110.20% |
2021 | 900.82M | -4.08% |
2020 | 939.10M | 7.33% |
2019 | 874.98M | 6.81% |
The current Enterprise Value of Immunocore Holdings plc (IMCR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.93B
5-year avg
1.52B
10-year avg
1.40B
Immunocore Holdings plc’s Enterprise Value is less than Arcellx, Inc. (3.80B), greater than Ventyx Biosciences, Inc. (123.69M), less than Vaxcyte, Inc. (11.96B), less than DICE Therapeutics, Inc. (2.21B), less than Nuvalent, Inc. (5.51B), greater than Viridian Therapeutics, Inc. (813.50M), less than Gracell Biotechnologies Inc. (0), less than Theseus Pharmaceuticals, Inc. (5.45B), greater than Monte Rosa Therapeutics, Inc. (138.26M), greater than Design Therapeutics, Inc. (284.72M), greater than Erasca, Inc. (221.42M), greater than Mirum Pharmaceuticals, Inc. (689.13M), less than Larimar Therapeutics, Inc. (2.05B), greater than KalVista Pharmaceuticals, Inc. (486.93M), greater than Lyra Therapeutics, Inc. (506.03M), greater than null (22.69M),
Company | Enterprise Value | Market cap |
---|---|---|
3.80B | $3.83B | |
123.69M | $153.35M | |
11.96B | $12.45B | |
2.21B | $2.27B | |
5.51B | $5.59B | |
813.50M | $900.21M | |
0 | $989.87M | |
5.45B | $181.50M | |
138.26M | $349.21M | |
284.72M | $264.42M | |
221.42M | $807.96M | |
689.13M | $1.96B | |
2.05B | $513.64M | |
486.93M | $531.63M | |
506.03M | $17.85M | |
22.69M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunocore Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immunocore Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Immunocore Holdings plc's Enterprise Value?
What is the highest Enterprise Value for Immunocore Holdings plc (IMCR)?
What is the 3-year average Enterprise Value for Immunocore Holdings plc (IMCR)?
What is the 5-year average Enterprise Value for Immunocore Holdings plc (IMCR)?
How does the current Enterprise Value for Immunocore Holdings plc (IMCR) compare to its historical average?